PASG (STOCKS)
Passage Bio, Inc. Common Stock
$5.500000
-0.310000 (-5.34%)
Prev close: $5.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William Chou
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17.64M
- Employees
- 60
- P/E (TTM)
- -0.46
- P/B (TTM)
- 1.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.16 | $-2.85 | +0.6858 | +24.10% |
|
Dec 2025 (Q4)
|
$-3.95 | $-2.62 | -1.3286 | -50.68% |
|
Sep 2025 (Q3)
|
$-2.44 | $-2.86 | +0.4160 | +14.57% |
|
Jun 2025 (Q2)
|
$-2.96 | $-4.13 | +1.1710 | +28.35% |
Financial Statements
| Research and Development | $19.63M |
| Operating Income/Loss | -$41.08M |
| Income/Loss From Continuing Operations After Tax | -$37.68M |
| Income/Loss From Continuing Operations Before Tax | -$37.68M |
| Net Income/Loss | -$37.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$37.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$11.85 |
| Diluted Earnings Per Share | -$11.85 |
| Basic Average Shares | 9,555,806 |
| Diluted Average Shares | 9,555,806 |
| Assets | $36.46M |
| Current Assets | $34.74M |
| Noncurrent Assets | $1.72M |
| Fixed Assets | $826.00K |
| Other Non-current Assets | $895.00K |
| Liabilities | $24.71M |
| Current Liabilities | $20.10M |
| Accounts Payable | $1.31M |
| Wages | $1.30M |
| Other Current Liabilities | $17.50M |
| Noncurrent Liabilities | $4.61M |
| Equity | $11.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.75M |
| Liabilities And Equity | $36.46M |
| Net Cash Flow From Operating Activities | -$30.65M |
| Net Cash Flow From Operating Activities, Continuing | -$30.65M |
| Net Cash Flow From Investing Activities | $605.00K |
| Net Cash Flow From Investing Activities, Continuing | $605.00K |
| Net Cash Flow From Financing Activities | $38.77M |
| Net Cash Flow From Financing Activities, Continuing | $38.77M |
| Net Cash Flow | $8.73M |
| Net Cash Flow, Continuing | $8.73M |
| Comprehensive Income/Loss | -$37.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.68M |
| Other Comprehensive Income/Loss | -$37.68M |